FEATURE POINT MATCHING BASED ON DISTINCT WAVELENGTH PHASE CONGRUENCY AND LOG-GABOR FILTERS IN INFRARED AND VISIBLE IMAGES

Feature Point Matching Based on Distinct Wavelength Phase Congruency and Log-Gabor Filters in Infrared and Visible Images

Infrared and visible image matching methods have been rising in popularity with the emergence of more kinds of sensors, which provide more applications in visual navigation, precision guidance, image fusion, and medical image analysis.In such applications, image matching is utilized for location, fusion, image analysis, and strikketøy oppbevaring

read more

Accurate diagnosis of spinal muscular atrophy and 22q11.2 deletion syndrome using limited deoxynucleotide triphosphates and high-resolution melting

Abstract Background Copy number variation (CNV) has been implicated in the genetics of multiple human diseases.Spinal muscular atrophy (SMA) and 22q11.2 deletion syndrome (22q11.2DS) are two of the catherine lansfield ombre rainbow clouds eyelet curtains most common diseases which are caused by DNA copy number variations.Genetic diagnostics for the

read more

MANAGERIAL ABILITY AS AN EFFORT TO IMPROVE SME PERFORMANCE THROUGH COMPETITIVE ADVANTAGE IN THE PANDEMIC TIME COVID 19

The purpose of this study was to investigate competitive advantage as a mediator for the influence of managerial ability on the performance of SMEs in Malang City.The population of this research is the owners of SMEs in Malang, amounting to 113,000 units engaged in food processing, handicraft, and handicraft business units.Sampling in this study us

read more

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)

Abstract Objective APPEASE is a phase I study to assess the safety, dosing, and efficacy of rivoceranib (a selective, small-molecule inhibitor of VEGFR2) in combination with pembrolizumab.We aimed to treat patients with metastatic malignancies citronella horse shampoo who have progressed through at least first-line therapy, with pembrolizumab 200 m

read more